Stereochemical specificity of Alzheimer's disease β-peptide assembly
✍ Scribed by William P. Esler; Evelyn R. Stimson; Jordan B. Fishman; Joseph R. Ghilardi; Harry V. Vinters; Patrick W. Mantyh; John E. Maggio
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1999
- Tongue
- English
- Weight
- 267 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
✦ Synopsis
The formation and growth of insoluble amyloid deposits composed primarily of the human -amyloid peptide (A) in brain is an essentially invariant feature of Alzheimer's disease (AD) and is widely believed to contribute to the progressive neurodegeneration of the disorder. To probe the specificity of amyloid formation and growth, we synthesized and examined the selfassembly of D-and L-stereoisomers of A in vitro. While both enantiomers formed insoluble aggregates at similar rates with amyloid-like fibrillar morphology, deposition of soluble A peptide onto preexisting A aggregates was stereospecific. Although the L-peptide deposited readily onto immobilized L-A aggregates with first-order kinetic dependence on soluble peptide concentration, essentially no association between the D-peptide and L-template was observed. Similarly, the D-peptide deposited with first-order kinetics onto a D-A aggregate template but did not deposit onto
📜 SIMILAR VOLUMES
## Abstract Amyloid formation plays a central role in the cause and progression of Alzheimer's disease. The major component of this amyloid is the amyloid‐β (Aβ) peptide, which is currently the subject of intense study. This review discusses some recent studies in the area of Aβ synthesis, purifica
## Abstract Although it is clear that amyloid beta (Aβ) peptides play a pivotal role in the development of Alzheimer's disease, the precise molecular model of action remains unclear. Aβ peptide forms assemble both in aqueous solution and in lipid membranes. It has been proposed that deleterious eff
Cocktail treatment is an effective multidrug medication therapy for some diseases, such as cancer and AIDS, because of the additive or synergistic effect of each medicine and relief from adverse effects. Amyloid-b peptide (Ab), which is now recognized as central to the development of Alzheimer's dis